RS49831B - Farmaceutske kompozicije tizoksanida i nitazoksanida - Google Patents
Farmaceutske kompozicije tizoksanida i nitazoksanidaInfo
- Publication number
- RS49831B RS49831B YUP-571/99A YU57199A RS49831B RS 49831 B RS49831 B RS 49831B YU 57199 A YU57199 A YU 57199A RS 49831 B RS49831 B RS 49831B
- Authority
- RS
- Serbia
- Prior art keywords
- pharmacedtical
- tizoxanide
- nitazoxanide
- compositions
- compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A61P33/12—Schistosomicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Farmaceutska kompozicija za oralnu primenu koja kao aktivno sredstvo barem jedno jedinjenje koje je odabrano iz grupe koju čine: jedinjenje formule (I) i jedinjenje formule (II) gde je pomenuto aktivno sredstvo u obliku aktivnih čestica čija je veličina manja od 200 μm i gde je srednja vrednost veličine čestice veća od 10μm.Prijava sadrži još 41 patentni zahtev.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/852,447 US5968961A (en) | 1997-05-07 | 1997-05-07 | Pharmaceutical compositions of tizoxanide and nitazoxanide |
US08/887,809 US5965590A (en) | 1994-09-08 | 1997-07-03 | Method for treatment of opportunistic infections with pharmaceutical compositions of tizoxanide and nitazoxanide |
US08/887,810 US5856348A (en) | 1994-09-08 | 1997-07-03 | Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide |
PCT/US1998/009229 WO1998050035A1 (en) | 1997-05-07 | 1998-05-06 | Pharmaceutical compositions of tizoxanide and nitazoxanide |
Publications (2)
Publication Number | Publication Date |
---|---|
YU57199A YU57199A (sr) | 2002-08-12 |
RS49831B true RS49831B (sr) | 2008-08-07 |
Family
ID=25313357
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YUP-571/99A RS49831B (sr) | 1997-05-07 | 1998-05-06 | Farmaceutske kompozicije tizoksanida i nitazoksanida |
RSP-2007/0379A RS50046B (sr) | 1997-05-07 | 1998-05-06 | Farmaceutske kompozicije tizoksanida i nitazoksanida |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RSP-2007/0379A RS50046B (sr) | 1997-05-07 | 1998-05-06 | Farmaceutske kompozicije tizoksanida i nitazoksanida |
Country Status (11)
Country | Link |
---|---|
US (2) | US5968961A (sr) |
AR (1) | AR008355A1 (sr) |
BG (1) | BG65679B1 (sr) |
CO (1) | CO4950538A1 (sr) |
CU (1) | CU23318A7 (sr) |
ID (1) | ID24828A (sr) |
LT (1) | LT4751B (sr) |
PL (1) | PL193556B1 (sr) |
RO (1) | RO122247B1 (sr) |
RS (2) | RS49831B (sr) |
ZA (1) | ZA983849B (sr) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7125568B2 (en) | 2001-08-23 | 2006-10-24 | Sung Michael T | Lipophilic drug compositions |
CA2467321A1 (en) * | 2004-05-14 | 2005-11-14 | Paul J. Santerre | Polymeric coupling agents and pharmaceutically-active polymers made therefrom |
UA90864C2 (en) * | 2004-09-09 | 2010-06-10 | Ромарк Лебораториз, Л.К. | Halogenated benzamide derivatives |
CA2604640A1 (en) * | 2005-04-12 | 2006-10-19 | Romark Laboratories L.C. | Methods for treating diseases through interruption of protein maturation, compounds that inhibit the function of molecular chaperones such as protein disulfide isomerases or interfere with glycosylation, pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents |
ZA200806310B (en) | 2006-01-09 | 2009-12-30 | Romark Lab Lc | Viral hepatitis treatment |
PL2395840T3 (pl) | 2009-02-13 | 2020-09-07 | Romark Laboratories, L.C. | Preparaty farmaceutyczne nitazoksanidu o kontrolowanym uwalnianiu |
SG10201402281WA (en) | 2009-05-12 | 2014-07-30 | Romark Lab Lc | Haloalkyl heteroaryl benzamide compounds |
BRPI1014322A2 (pt) | 2009-06-26 | 2015-08-25 | Romark Lab Lc | Método para tratar infecção, e para interromper ou evitar a produção de partículas virais infecciosas, combinação, e, composição farmacêutica. |
ES2767304T3 (es) | 2011-05-16 | 2020-06-17 | Romark Laboratories Lc | Utilización de compuestos de tiazolida para la prevención y el tratamiento de enfermedades víricas, cáncer y enfermedades causadas por infecciones intracelulares |
BR112014018149B1 (pt) * | 2012-01-27 | 2020-09-29 | Siegfried Rhein S.A. De C.V | Composição farmacêutica de nitazoxanida |
US20140306689A1 (en) | 2013-04-10 | 2014-10-16 | Texas Instruments, Incorporated | High resolution current pulse analog measurement |
JP6633092B2 (ja) | 2014-11-11 | 2020-01-22 | ロマーク ラボラトリーズ,リミティド カンパニー | チゾキサニド、その類似体又は塩のプロドラッグを用いる組成物及び治療方法 |
CA3113354A1 (en) | 2016-03-31 | 2017-10-05 | Romark Laboratories, L.C. | Thiazolide compounds for treating viral infections |
EP3777855B1 (en) | 2016-04-11 | 2022-10-19 | Genfit | Methods of treatment for fibrotic diseases |
US11173149B2 (en) | 2017-04-18 | 2021-11-16 | Romark Laboratories L.C. | Inhibition of protein disulfide-isomerase A3 |
US11612567B2 (en) | 2018-02-02 | 2023-03-28 | Ripple Therapeutics Corporation | Ocular inserts comprising a covalently linked steroid dimer |
CA3176134A1 (en) | 2020-05-01 | 2021-11-04 | Ripple Therapeutics Corporation | Heterodimer compositions and methods for the treatment of ocular disorders |
JP2023537237A (ja) | 2020-07-20 | 2023-08-31 | ロマーク ラボラトリーズ,リミティド カンパニー | チゾキサニドおよび2-ヒドロキシ-n-(5-クロロ-1,3-チアゾル-2-イル)ベンズアミド(rm-4848)とエタノールアミン、モルホリン、プロパノールアミン、ピペラジン、およびn-メチルピペラジンの結晶塩 |
US20230330069A1 (en) | 2020-08-24 | 2023-10-19 | Romark Laboratories, L.C. | Use of thiazolides against coronaviruses |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1437800A (en) * | 1973-08-08 | 1976-06-03 | Phavic Sprl | Derivatives of 2-benzamido-5-nitro-thiazoles |
US4315018A (en) * | 1978-12-07 | 1982-02-09 | Rossignol Jean F | Specific parasiticidal use of 2-benzamido-5-nitro-thiazole derivatives |
US5496809A (en) * | 1989-05-10 | 1996-03-05 | Bristol-Myers Squibb Co | Stable solutions of rebeccamycin analog |
US5578621A (en) * | 1994-09-08 | 1996-11-26 | Romark Lab Lc | Benzamide derivatives |
DE69526936T2 (de) | 1994-04-13 | 2003-02-20 | Romark Lab Lc | Benzamide-derivate, zubereitungen die sie erhalten und ihre anwendung |
US5387598A (en) * | 1994-04-13 | 1995-02-07 | Rossignol; Jean-Francois | Composition and galenic formulation suitable for combatting affections of the lower abdomen |
-
1997
- 1997-05-07 US US08/852,447 patent/US5968961A/en not_active Expired - Lifetime
-
1998
- 1998-05-06 RS YUP-571/99A patent/RS49831B/sr unknown
- 1998-05-06 ID IDW991540A patent/ID24828A/id unknown
- 1998-05-06 RS RSP-2007/0379A patent/RS50046B/sr unknown
- 1998-05-06 RO ROA200500768A patent/RO122247B1/ro unknown
- 1998-05-06 PL PL98379247A patent/PL193556B1/pl not_active IP Right Cessation
- 1998-05-06 US US09/073,436 patent/US6117894A/en not_active Expired - Lifetime
- 1998-05-07 CO CO98025363A patent/CO4950538A1/es unknown
- 1998-05-07 AR ARP980102114A patent/AR008355A1/es active IP Right Grant
- 1998-05-07 ZA ZA9803849A patent/ZA983849B/xx unknown
-
1999
- 1999-12-06 BG BG109365A patent/BG65679B1/bg unknown
- 1999-12-06 LT LT99-141A patent/LT4751B/lt not_active IP Right Cessation
-
2003
- 2003-04-03 CU CU20030074A patent/CU23318A7/es unknown
Also Published As
Publication number | Publication date |
---|---|
CU23318A7 (es) | 2008-10-22 |
BG65679B1 (bg) | 2009-06-30 |
AR008355A1 (es) | 2000-01-19 |
US5968961A (en) | 1999-10-19 |
RS50046B (sr) | 2008-11-28 |
RO122247B1 (ro) | 2009-03-30 |
YU57199A (sr) | 2002-08-12 |
ID24828A (id) | 2000-08-24 |
LT4751B (lt) | 2001-01-25 |
RS20070379A (en) | 2008-06-05 |
US6117894A (en) | 2000-09-12 |
PL193556B1 (pl) | 2007-02-28 |
ZA983849B (en) | 1999-08-27 |
CO4950538A1 (es) | 2000-09-01 |
LT99141A (en) | 2000-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS49831B (sr) | Farmaceutske kompozicije tizoksanida i nitazoksanida | |
YU13695A (sh) | Upotreba 2-fenil-3-aroilbenzotiofena i njihove farmaceutske formulacije | |
YU49698A (sh) | Smeše koje sadrže tetrahidrolipstatin | |
AU4264396A (en) | Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof | |
DE69318503T2 (de) | Ein definiertes lipidsystem enthaltende pharmazeutische zusammensetzung | |
ATE324907T1 (de) | Verbindung und arzneizusammensetzung zur verabreichung von wirkstoffen | |
ATE271383T1 (de) | Pulverformulierung zur inhalation | |
IL111647A (en) | Pharmaceutical compositions comprising microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles and their preparation | |
RS49566B (sr) | Kompozicije koje sadrže antifungicidno sredstvo i acetatni pufer | |
HRP20010243B1 (en) | Compositions containing diphosphonic acids | |
UA27899C2 (uk) | Порошкова антибактеріальна композиція, що призначена для орального використання, яка містить гідратований цефтибутен | |
RS50303B (sr) | Farmaceutska kompozicija nimesulida sa kontrolisanim oslobađanjem | |
RS50937B (sr) | Farmaceutska kompozicija koja sadrži metformin i glibenklamid za lečenje šećerne bolesti tipa ii | |
KR970705553A (ko) | 디히드로벤조푸란, 및 항염증 약물로서 유용한 관련 화합물(dihydrobenzofuran and related compounds useful as anti-inflammatory agents) | |
DE69925293D1 (de) | Sprühbeschichtete mikropartikel für nadellose spritzen | |
ME00530B (me) | Farmaceutske kompozicije tizoksanida i nitazoksanida | |
HUP0203226A2 (hu) | Hatóanyagként benzamidszármazékot tartalmazó gyógyszerkészítmény | |
DE69827466D1 (de) | Geschmacksneutrale pharmazeutische zusammensetzungen | |
IL114968A (en) | 1,4-dihydropyridine compounds and pharmaceutical compositions containing them | |
GEP20032975B (en) | Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition | |
AU2001237768A1 (en) | Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis | |
ECSP982778A (es) | Nuevas composiciones que tienen actividad terapeutica en forma de particulas |